Top compounds associated with response to CTC-429P9.4


Feature Type Standardized
Nominal ANOVA
mRNA WZ8040 CTRPv2 pan-cancer AAC -0.057 0.1
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.053 0.1
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.054 0.1
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.051 0.1
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.052 0.1
mRNA BRD-K19103580 CTRPv2 pan-cancer AAC -0.054 0.1
mRNA ibrutinib CTRPv2 pan-cancer AAC -0.061 0.1
mRNA pluripotin CTRPv2 pan-cancer AAC -0.051 0.1
mRNA BRD-K45681478 CTRPv2 pan-cancer AAC 0.051 0.2
mRNA CAY10618 CTRPv2 pan-cancer AAC -0.049 0.2
Download CSV